Skip to main content
Indegene Limited logo

Indegene Limited — Investor Relations & Filings

Ticker · INDGN ISIN · INE065X01017 LEI · 335800XFEREFIW9LG995 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2025-12-31 Remuneration Information
Country IN India
Listing BSE.NS INDGN

About Indegene Limited

https://www.indegene.com/

Indegene Limited provides digital-led commercialization services for the life sciences sector. The company integrates deep domain knowledge with proprietary technology platforms to assist biopharmaceutical, emerging biotech, and medical device organizations. Its core offerings span the entire product lifecycle, including clinical development support, regulatory compliance, pharmacovigilance, and multi-channel marketing operations. By leveraging artificial intelligence and machine learning, Indegene enables clients to optimize drug development processes, enhance patient engagement, and drive operational efficiencies. The company focuses on modernizing traditional commercial models through data-driven insights and digital transformation strategies, helping global healthcare organizations navigate complex regulatory environments and improve health outcomes through scaled, technology-enabled solutions.

Recent filings

Filing Released Lang Actions
ESOP/ESOS/ESPS
Remuneration Information Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the approval of grants under the RSU 2020 Plan by the Nomination and Remuneration Committee. It details the stock option grant specifics, vesting schedule, and exercise price. This type of disclosure relates to remuneration and stock-based compensation plans for employees and executives. It is not an annual report, earnings release, or management discussion. It is not a proxy statement or voting result. The document is a regulatory announcement about remuneration-related stock option grants, fitting the category of Remuneration Information (DEF 14A). The document length is short and focused on remuneration details, not a full report or financial statement.
2025-12-31 English
Acquisition
Capital/Financing Update Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the acquisition of 100% equity shares in Trilogy Writing & Consulting Inc. by the company's subsidiaries. It includes details about the target company, the nature of the transaction, consideration, and other acquisition-related information. This type of disclosure is typical of a Capital/Financing Update as it informs the market about a significant corporate transaction affecting the company's capital structure or subsidiaries. The document is not a full financial report, audit, or earnings release, nor is it a regulatory filing or announcement of a report publication. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content support a high confidence in this classification.
2025-12-31 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window for insiders due to the upcoming finalization and approval of quarterly financial results for the period ending December 31, 2025. It references SEBI regulations on insider trading and the company's internal code of conduct. The document does not contain any financial data, results, or detailed report content but is an announcement related to trading restrictions ahead of financial results disclosure. The document length is short (1801 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance-related notices that do not fit other categories.
2025-12-29 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a newspaper advertisement of a postal ballot notice. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions that the postal ballot notice has been published in newspapers and will be posted on the company's website. The document does not contain any financial data, management discussion, voting results, or detailed report content. It is essentially an announcement informing the exchanges about the publication of the postal ballot notice. The document length is about 12,834 characters, but the content is primarily an announcement of a notice publication rather than the notice itself or any detailed report. Therefore, according to the "Menu vs Meal" rule, this is a Report Publication Announcement (RPA) type filing, as it announces the publication of a postal ballot notice without including the full notice or substantive content.
2025-12-23 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice issued by Indegene Limited dated December 22, 2025. It details the proposal for appointment of an Independent Director, the voting process via remote e-voting, and the timeline for voting and announcement of results. The document references compliance with the Companies Act, SEBI Listing Obligations, and other regulatory provisions. It is a notice sent to shareholders to seek approval on a resolution through postal ballot (electronic voting). It is not a report of voting results, nor a management or financial report. It is a solicitation for shareholder approval via postal ballot, which fits the category of Proxy Solicitation & Information Statement (PSI). The document is lengthy (15,000 characters) and contains the full notice and explanatory statement, not just an announcement or brief summary. Therefore, the appropriate classification is PSI with high confidence.
2025-12-22 English
ESOP/ESOS/ESPS
Board/Management Information Classification · 100% confidence The document is a formal disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to announcements about changes in the company's board of directors or senior management. The content details the appointment of a new Non-Executive Independent Director, including his profile, term, and compliance affirmations. There are no financial statements or performance data, nor is this an announcement of a report publication. This fits the category of Board/Management Information (MANG). The document length is 4038 characters, which is consistent with a detailed management change announcement rather than a full report or a brief notice.
2025-12-19 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.